Diagnostic significance of reduced serum caeruloplasmin concentration in neurological disease
Identifieur interne : 001B32 ( Istex/Curation ); précédent : 001B31; suivant : 001B33Diagnostic significance of reduced serum caeruloplasmin concentration in neurological disease
Auteurs : John M. Walshe [Royaume-Uni]Source :
- Movement Disorders [ 0885-3185 ] ; 2005-12.
English descriptors
Abstract
This study covers patients seen at a Wilson disease clinic between 1960 and 2002. The diagnosis of Wilson disease was confirmed in 316. Of 40 patients with a neurological presentation who were found not to have the disease, caeruloplasmin concentration was found to be reduced in 19. These 19 patients comprised 17 men and 2 women. The various diagnoses included Huntington's disease, multiple sclerosis, subacute sclerosing panencephalitis (SSPE), Hallervorden Spatz syndrome, and acaeruloplasminemia; in 9 no definite diagnosis was made. In view of the marked male preponderance, the lower limit of caeruloplasmin is calculated as for males. In an earlier study this was found to be 33.3 mg/dl (standard deviation, 6.1 mg/dl); therefore, 21.1 mg/dl is taken as the lower limit of normal. Particular attention is paid to 3 patients, 2 of whom had zero concentrations of caeruloplasmin and 1 had a very low level of the protein. Only 1 of these patients conformed to the classical picture of acaeruloplasminemia. The significance of a low caeruloplasmin concentration in patients with a variety of neurological syndromes is not clear but can lead to diagnostic confusion. When the concentration of this protein is very low or absent the diagnosis of acaeruloplasminemia must be considered. © 2005 Movement Disorder Society
Url:
DOI: 10.1002/mds.20628
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001B32
Links to Exploration step
ISTEX:2F3DA4DB0A949E8E6922B02FCBF8B326F3591B63Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Diagnostic significance of reduced serum caeruloplasmin concentration in neurological disease</title><author><name sortKey="Walshe, John M" sort="Walshe, John M" uniqKey="Walshe J" first="John M." last="Walshe">John M. Walshe</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, The Middlesex Hospital, London, United Kingdom</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Neurology, The Middlesex Hospital, London</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:2F3DA4DB0A949E8E6922B02FCBF8B326F3591B63</idno><date when="2005" year="2005">2005</date><idno type="doi">10.1002/mds.20628</idno><idno type="url">https://api.istex.fr/document/2F3DA4DB0A949E8E6922B02FCBF8B326F3591B63/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001B32</idno><idno type="wicri:Area/Istex/Curation">001B32</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Diagnostic significance of reduced serum caeruloplasmin concentration in neurological disease</title><author><name sortKey="Walshe, John M" sort="Walshe, John M" uniqKey="Walshe J" first="John M." last="Walshe">John M. Walshe</name><affiliation wicri:level="1"><mods:affiliation>Department of Neurology, The Middlesex Hospital, London, United Kingdom</mods:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Neurology, The Middlesex Hospital, London</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2005-12">2005-12</date><biblScope unit="vol">20</biblScope><biblScope unit="issue">12</biblScope><biblScope unit="page" from="1658">1658</biblScope><biblScope unit="page" to="1661">1661</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">2F3DA4DB0A949E8E6922B02FCBF8B326F3591B63</idno><idno type="DOI">10.1002/mds.20628</idno><idno type="ArticleID">MDS20628</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Wilson disease</term><term>acaeruloplasminemia</term><term>diagnosis</term><term>serum caeruloplasmin</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This study covers patients seen at a Wilson disease clinic between 1960 and 2002. The diagnosis of Wilson disease was confirmed in 316. Of 40 patients with a neurological presentation who were found not to have the disease, caeruloplasmin concentration was found to be reduced in 19. These 19 patients comprised 17 men and 2 women. The various diagnoses included Huntington's disease, multiple sclerosis, subacute sclerosing panencephalitis (SSPE), Hallervorden Spatz syndrome, and acaeruloplasminemia; in 9 no definite diagnosis was made. In view of the marked male preponderance, the lower limit of caeruloplasmin is calculated as for males. In an earlier study this was found to be 33.3 mg/dl (standard deviation, 6.1 mg/dl); therefore, 21.1 mg/dl is taken as the lower limit of normal. Particular attention is paid to 3 patients, 2 of whom had zero concentrations of caeruloplasmin and 1 had a very low level of the protein. Only 1 of these patients conformed to the classical picture of acaeruloplasminemia. The significance of a low caeruloplasmin concentration in patients with a variety of neurological syndromes is not clear but can lead to diagnostic confusion. When the concentration of this protein is very low or absent the diagnosis of acaeruloplasminemia must be considered. © 2005 Movement Disorder Society</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B32 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 001B32 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:2F3DA4DB0A949E8E6922B02FCBF8B326F3591B63
|texte= Diagnostic significance of reduced serum caeruloplasmin concentration in neurological disease
}}
| This area was generated with Dilib version V0.6.23. |  |